Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants-Reference-Cited by-同舟云学术

Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants

Published:2017-11-28 Issue:18 Volume:31 Page:2455-2463
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Ewing Alexander C.,King Caroline C.,Wiener Jeffrey B.,Chasela Charles S.,Hudgens Michael G.,Kamwendo Debbie,Tegha Gerald,Hosseinipour Mina C.,Jamieson Denise J.,Van der Horst Charles,Kourtis Athena P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference27 articles.

1. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial;Chintu;Lancet,2004

2. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda;Mermin;Lancet,2004

3. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial;Anglaret;Lancet,1999

4. Etiology and natural history of neutropenia in human immunodeficiency virus disease: a prospective study;Moore;Clin Infect Dis,2001

5. Frequency and risk factors of infectious complications in neutropenic patients infected with HIV;Meynard;AIDS,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy—Update 2022: Systematic Review;Pharmaceutics;2023-10-18

2. Statistical Inferences of HIVRNA and Fracture Based on the PAK1 Expression via Neural Network Model;Current HIV Research;2023-04-13

3. Cotrimoxazole Prophylaxis Selects for Antimicrobial Resistance in Human Immunodeficiency Virus–Exposed, Uninfected Infants;Clinical Infectious Diseases;2019-12-13

4. Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004–2010;Emerging Infectious Diseases;2019-01